MedTrace Logo

The Effects of Chicken Extract and a Peptide Supplement for the Prevention of Cognitive Decline in Non-demented Elderly Adults

NCT04555655 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 276

Last updated 2025-09-16

No results posted yet for this study

Summary

This trial investigates the effect of a chicken extract supplement and a peptide supplement on cognitive function and potential mechanisms of action of cognitive decline during ageing, among non-demented elderly adults using a three-arm, randomized, placebo-controlled clinical trial design.

Conditions

Interventions

DIETARY_SUPPLEMENT

Chicken extract supplement

70ml of chicken extract supplement to be consumed daily in the morning before meals for 2 years.

DIETARY_SUPPLEMENT

Peptide Supplement

70ml of Peptide Supplement (670mg) to be consumed daily in the morning before meals for 2 years.

OTHER

Placebo

70ml of placebo (caesinate) to be consumed daily in the morning before meals for 2 years.

Sponsors & Collaborators

  • Taipei Medical University Shuang Ho Hospital

    collaborator OTHER

  • National Cheng-Kung University Hospital

    collaborator OTHER

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • Brand's Suntory Asia

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-11
Primary Completion
2024-11-15
Completion
2025-01-08

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04555655 on ClinicalTrials.gov